Cargando…
Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A
BACKGROUND: Accumulation of hyperphosphorylated tau is a major neuropathological feature of tauopathies including Alzheimer’s disease (AD). Serum amyloid A (SAA), an acute-phase protein with cytokine-like property, has been implicated in amyloid deposition. It remains unclear whether SAA affects tau...
Autores principales: | Liu, Jin, Wang, Ding, Li, Shu-Qin, Yu, Yang, Ye, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736117/ https://www.ncbi.nlm.nih.gov/pubmed/26838764 http://dx.doi.org/10.1186/s12974-016-0493-y |
Ejemplares similares
-
Indirubin-3′-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation
por: Zhang, Shu-gang, et al.
Publicado: (2016) -
Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013) -
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer’s disease
por: Li, Shu-Qin, et al.
Publicado: (2015) -
Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
por: Taylor, Henry B.C., et al.
Publicado: (2021) -
Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
por: Burns, Lindsay H., et al.
Publicado: (2017)